Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.56NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.56NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.4.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.4.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.4.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.198NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.198NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.198NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.366NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.366NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.366NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.441NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.441NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.441NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.416NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.416NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.416NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.63NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.63NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.63NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.263NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.263NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.263NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.135NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.135NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.135NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FK.1.4.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FK.1.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FK.1.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.13NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DR.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DR.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DR.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.15NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.160.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.15NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.219NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.219NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.219NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
N.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.208NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.208NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.208NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.125.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.125.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.125.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used